• Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +9
  • Corabotase for Moderate to Severe Glabellar Lines in Adults

    Not recruiting

    3 1
    France Germany
  • Study on the Effectiveness and Safety of CR9114 for Preventing Influenza in Healthy Adults

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium
  • Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium Denmark France Germany Hungary Italy +4
  • Efficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial

    Not recruiting

    4 1
    Investigated Drugs:
    France Germany Italy The Netherlands Spain
  • A study to test if tibulizumab works and is safe for adults with systemic sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    Hungary Poland Romania Spain
  • A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Germany Hungary Ireland Poland
  • Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

    Not recruiting

    2 1
    Investigated Drugs:
    France Germany Greece Italy Poland Spain
  • Long-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Finland France Germany +4

powered by